BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 22281514)

  • 1. Chemotherapy and fertility.
    Blumenfeld Z
    Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):379-90. PubMed ID: 22281514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
    Blumenfeld Z
    Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects.
    Reichman BS; Green KB
    J Natl Cancer Inst Monogr; 1994; (16):125-9. PubMed ID: 7999454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of breast cancer treatment on fertility.
    de la Haba-Rodríguez J; Calderay M
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():59-63. PubMed ID: 20711656
    [No Abstract]   [Full Text] [Related]  

  • 5. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a.
    Blumenfeld Z; Eckman A
    J Natl Cancer Inst Monogr; 2005; (34):40-3. PubMed ID: 15784821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of gonadal damage during cytotoxic therapy.
    Blumenfeld Z; Haim N
    Ann Med; 1997 Jun; 29(3):199-206. PubMed ID: 9240625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
    Blumenfeld Z
    Oncologist; 2007 Sep; 12(9):1044-54. PubMed ID: 17914074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
    Decanter C; Robin G
    Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility preservation options for women with malignancies.
    Marhhom E; Cohen I
    Obstet Gynecol Surv; 2007 Jan; 62(1):58-72. PubMed ID: 17176489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers.
    Blumenfeld Z
    Mol Cell Endocrinol; 2002 Feb; 187(1-2):93-105. PubMed ID: 11988316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for fertility preservation in young early breast cancer patients.
    Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
    Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Breast cancer and fertility: critical review, considerations and perspectives].
    This P
    Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian rescue/protection from chemotherapeutic agents.
    Blumenfeld Z
    J Soc Gynecol Investig; 2001; 8(1 Suppl Proceedings):S60-4. PubMed ID: 11223377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present and future fertility preservation strategies for female cancer patients.
    Georgescu ES; Goldberg JM; du Plessis SS; Agarwal A
    Obstet Gynecol Surv; 2008 Nov; 63(11):725-32. PubMed ID: 18928577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
    Roness H; Kalich-Philosoph L; Meirow D
    Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation in women with CNS tumors.
    Tosoni A; Balestrini D; Brandes AA
    Expert Rev Anticancer Ther; 2017 May; 17(5):439-445. PubMed ID: 28395560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian damage from chemotherapy and current approaches to its protection.
    Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
    Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility preservation in young women undergoing breast cancer therapy.
    Sonmezer M; Oktay K
    Oncologist; 2006 May; 11(5):422-34. PubMed ID: 16720842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.